Risk Of Offensive/Incorrect Content: Pioneers at Children’s Hospital of Philadelphia Greet European Commission’s Approval of Kymriah as Landmark Medical Advance for Young Cancer Patients in Europe

Oncologists from Children’s Hospital of Philadelphia today celebrated a watershed moment in medicine: approval by the European Commission of Kymriah (tisagenlecleucel, formerly CTL019) –the first-ever FDA-approved personalized CAR T-cell gene immunoth…

read more